AP Biosciences, Inc. (TPEX:6945)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
86.50
-2.30 (-2.59%)
Jul 30, 2026, 11:25 AM CST

AP Biosciences Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8,61315,3204,2233,017--
Market Cap Growth
46.87%262.77%39.97%---
Enterprise Value
7,57314,1092,5592,131--
Last Close Price
88.80180.0049.7546.60--
PS Ratio
---93.55--
PB Ratio
7.1512.052.603.85--
P/TBV Ratio
7.1712.082.613.87--
EV/Sales Ratio
---66.08--
Debt / Equity Ratio
0.050.050.040.11--
Net Debt / Equity Ratio
-0.86-0.87-0.91-0.84-0.98-1.00
Net Debt / EBITDA Ratio
2.282.513.391.913.723.12
Net Debt / FCF Ratio
2.702.954.051.983.893.23
Asset Turnover
---0.03-0.01
Quick Ratio
33.7329.7339.7724.77241.9126.35
Current Ratio
33.9929.9439.8724.80242.1026.67
Return on Equity (ROE)
-32.48%-30.74%-35.13%-36.04%-34.83%-31.24%
Return on Assets (ROA)
--18.45%-20.96%-21.78%-22.10%-18.95%
Return on Capital Employed (ROCE)
-37.60%-34.50%-26.00%-40.40%-27.10%-33.50%
Earnings Yield
-5.33%-2.90%-10.01%-11.24%--
FCF Yield
-4.48%-2.46%-8.61%-11.03%--
Buyback Yield / Dilution
-6.37%-13.06%-16.28%-22.98%-118.32%-75.62%